Top 10 Drug Delivery Technologies Market research report intensively evaluates drug delivery technologies with respect to revenues, growth, therapeutic areas, patents registered and industry focus to arrive at top 10 drug delivery technologies - http://www.marketsandmarkets.com/Market-Reports/top-10-drug-delivery-technologies-112.html.
(PRWEB) March 23, 2014
The ‘Global Top 10 Drug Delivery Technologies Market (2010 – 2015)’ analyzes the drug delivery technologies market by the top 10 drug delivery technologies and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and ROW.
Browse market data tables and in-depth TOC on "Global Top 10 Drug Delivery Technologies Market".
http://www.marketsandmarkets.com/Market-Reports/top-10-drug-delivery-technologies-112.html
Early buyers will receive 10% customization on this report.
The global top 10 drug delivery technologies market is expected to grow from $43.8 billion in 2009 to $81.5 billion in 2015, at an estimated CAGR of 11% from 2010 to 2015. Prominent industry participants include Elan, Biovail, Nektar, Alkermes & Nektar.
Inquiry Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=112
The rising demand for effective delivery of novel biopharmaceuticals is driving the growth of the global top 10 drug delivery technologies market. Further, patent expirations of drugs is also boosting market growth.
More than 25% of the marketed drugs fail to provide expected commercial returns due to drug distribution and absorption levels within the body (pharmacokinetics) therefore signifying the importance of drug delivery systems. Rapid enhancements in drug discovery technologies have lead to developments in proteomics and genomics and had a greater impact on drug delivery technology market. The changing market trends, with quick cycle of innovations have compelled market participants to clearly understand changing dynamics and focus on emerging technology and enhance market positions in terms of revenues, growth and geographical presence.
Ask for Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=112
Drug delivery technologies are revenue boosters for the pharmaceutical industry as they enhance drug life cycle in the market by extending patent rights, adding a competitive edge to the drug by enhancing their safety and efficacy. Further, expansion of the applications of non conventional modes of drug delivery such as pulmonary, nasal and transdermal in disease conditions other than respiratory and skin, especially in chronic disease conditions such as diabetes, CNS are also boosting the market. In addition, innovations such as microneedle transdermal patches and novel intelligent inhalers are also adding to the market growth. However, recent drug failures such as Exubera by Pfizer is a hindrance for the market.
Time release technologies account for the largest share around 10% of the top 10 drug delivery technologies market owing to the popularity of once daily formulations. Time release technologies market is expected to grow from US$8.5 billion in 2009 to Enormous opportunities lie in the area of unconventional technologies such as pulmonary, nasal and transdermal drug delivery due to technology innovations and expanded applications especially in chronic disease conditions.
Browse Related Reports:
Hospital Asset Management Market - Pharmaceutical [Wi-Fi RTLS, RFID (Tags – Active & Passive, Software), IR, Ultrasound, Equipment & Patient Tracking, Staff Safety, Temperature & Humidity Monitoring, Drug Counterfeit] - Global Forecast to 2017
http://www.marketsandmarkets.com/Market-Reports/healthcare-and-pharmaceuticals-asset-management-market-1195.html
Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets Reported by PRWeb 4 hours ago.
(PRWEB) March 23, 2014
The ‘Global Top 10 Drug Delivery Technologies Market (2010 – 2015)’ analyzes the drug delivery technologies market by the top 10 drug delivery technologies and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and ROW.
Browse market data tables and in-depth TOC on "Global Top 10 Drug Delivery Technologies Market".
http://www.marketsandmarkets.com/Market-Reports/top-10-drug-delivery-technologies-112.html
Early buyers will receive 10% customization on this report.
The global top 10 drug delivery technologies market is expected to grow from $43.8 billion in 2009 to $81.5 billion in 2015, at an estimated CAGR of 11% from 2010 to 2015. Prominent industry participants include Elan, Biovail, Nektar, Alkermes & Nektar.
Inquiry Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=112
The rising demand for effective delivery of novel biopharmaceuticals is driving the growth of the global top 10 drug delivery technologies market. Further, patent expirations of drugs is also boosting market growth.
More than 25% of the marketed drugs fail to provide expected commercial returns due to drug distribution and absorption levels within the body (pharmacokinetics) therefore signifying the importance of drug delivery systems. Rapid enhancements in drug discovery technologies have lead to developments in proteomics and genomics and had a greater impact on drug delivery technology market. The changing market trends, with quick cycle of innovations have compelled market participants to clearly understand changing dynamics and focus on emerging technology and enhance market positions in terms of revenues, growth and geographical presence.
Ask for Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=112
Drug delivery technologies are revenue boosters for the pharmaceutical industry as they enhance drug life cycle in the market by extending patent rights, adding a competitive edge to the drug by enhancing their safety and efficacy. Further, expansion of the applications of non conventional modes of drug delivery such as pulmonary, nasal and transdermal in disease conditions other than respiratory and skin, especially in chronic disease conditions such as diabetes, CNS are also boosting the market. In addition, innovations such as microneedle transdermal patches and novel intelligent inhalers are also adding to the market growth. However, recent drug failures such as Exubera by Pfizer is a hindrance for the market.
Time release technologies account for the largest share around 10% of the top 10 drug delivery technologies market owing to the popularity of once daily formulations. Time release technologies market is expected to grow from US$8.5 billion in 2009 to Enormous opportunities lie in the area of unconventional technologies such as pulmonary, nasal and transdermal drug delivery due to technology innovations and expanded applications especially in chronic disease conditions.
Browse Related Reports:
Hospital Asset Management Market - Pharmaceutical [Wi-Fi RTLS, RFID (Tags – Active & Passive, Software), IR, Ultrasound, Equipment & Patient Tracking, Staff Safety, Temperature & Humidity Monitoring, Drug Counterfeit] - Global Forecast to 2017
http://www.marketsandmarkets.com/Market-Reports/healthcare-and-pharmaceuticals-asset-management-market-1195.html
Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets Reported by PRWeb 4 hours ago.